Skip to main content

Author: The Wistar Institute

Navigating a Science Career: Wistar Alumni Share Their Career Journey at Inaugural Fireside Chat

Three Wistar alumni returned to their research roots to participate in Wistar’s first Fireside Chat forum as part of the Institute’s Diversity in Science initiative. In front of a video projection of a crackling fire, the trio spoke with humor, thoughtfulness, and disarming honesty to Wistar trainees about their career paths and what they’ve learned since leaving their respective Wistar labs.

The alumni – M. Cecilia Caino, Ph.D., Associate Professor of Pharmacology at the University of Colorado; Kevin Alicea-Torres, Ph.D., Assistant Professor of Cell & Molecular Biology at the University of Puerto Rico at Humacao; and Ademi Santiago-Walker, Ph.D. Head of Prostate and CRC Oncology Translation Research at Janssen Pharmaceutical – have diverged on their own unique paths, but agreed that their experiences and their Wistar connections were instrumental in helping them find their footing in academia and the corporate sector. 

Dr. Santiago-Walker, who trained as a postdoc in Dr. Meenhard Herlen’s lab, attributed her smooth transition into the pharmaceutical industry to the skills she learned at Wistar. “I use a lot of the transferable skills I learned in my time here,” she explained. “[Wistar] is a well-oiled machine and there’s a lot of great collaboration, so I had the opportunity to work in a matrixed team similar to what you have in pharma, where you’re working with multiple people from different functions to accomplish your goal.” 

Dr. Alicea-Torres explained that he received his Ph.D. just as the pandemic hit, adding an unplanned layer of complexity to the next step of his career. Although his path wasn’t clearly mapped out, he landed a Mass Media Fellowship that eventually led to a job as a science writer at Telemundo, something that combined his interest in communication with his scientific background. “I used my relationships to establish a network and learn about other opportunities. Networking is crucial, both inside and outside of the science community.” 

Throughout the wide-ranging discussion, the panelists answered a host of questions posed by the audience of trainees, including how to deal with self-doubt, diversifying your skillset, and ways to acquire “soft skills.”

“We’re always working on ourselves,” said Dr. Alicia-Torres. “Be humble throughout the process and be open to the feedback and advice that you receive. People may be observing something that you don’t see, and that might be the very thing you need to address to get that opportunity.”

The event was a joint effort between The Wistar Institute Inclusion Diversity & Equity Council (W-IDE), the Hubert J.P. Schoemaker Education and Training Center, and The Wistar Institute Trainee Association. Long term, the team plans to organize similar events to help budding researchers broaden their skills and learn from real-life experiences. “This event has been an amazing collaboration between a lot of different departments,” said Dr. Jessie Villanueva. “I hope that it’s the beginning of a new partnership between all of us to bring in similar future events.”

The Fireside Chat concluded with a networking reception that featured industry professionals from several local organizations including Spark Therapeutics, American Association of Cancer Research, and the University of Pennsylvania.

Notes from the Field: Dr. Ian Tietjen in Africa, Part 5

Dr. Ian Tietjen is a Research Assistant Professor in Wistar’s Montaner Lab, where he investigates traditional African medicinal compounds’ potential for drug origination against viruses like HIV. Dr. Tietjen travels to Africa to work with traditional healers to better understand the function of these compounds.

If you haven’t started this series with part one, click here.

9 August 2023 — After the big community session and the experimental workshop, today was a lighter day with the group. We travelled to Domboshaba, which is a cultural heritage site for the Kalanga peoples that was excavated nearly 100 years ago. The healers pointed out numerous plants that are used for medicines. The place has long been a site for training healers and general spiritual contact with the ancestors. After lunch, we gave some final speeches, and both the Secwepemc delegation and Kalanga healers serenaded all of us with their traditional songs. The healers are being driven home to their local villages or as far as Francistown.

They’re excited to work with biomedical researchers in a way that shares the benefits of collaboration between scientific partners.

Entrance and walk to the historic village.
On the left is a grinding stone and a wall continually rebuilt by people looking to preserve the village and continually torn down by baboons looking for insects to eat. Today the people won. On the right is the Chief’s residence, on top of a large hill. 

10 August 2023 — Today our group of researchers and some healers took a cultural trip out to the Elephant Sands park, where there are very few people but lots of wildlife. There is a watering hole nearby, and the elephants come up very close to you while you are eating lunch. 

Apart from the occasional village, herds of cattle, and the random elephant, it’s pretty much this for four hours. You don’t want to drive this road at night because the wildlife is frequently much larger than you.
On the left are weaver bird nests. In the middle is our van stuck in the sand. We all pushed and got it out, and the elephants stayed away. On the right are grass harvesters (for thatch, brooms, and other necessities.) returning home for the night. 
On the left is a very big tree. If you look close you can see Rhona at the bottom. On the right is what’s left of a large cattle herd.

On the way back one of the healers seemed to be getting more comfortable with us, asking a lot of questions about how HIV works and health science advice more generally. Afterwards, he treated us all to cups of sour milk from a roadside stand that also had Mopani worms, which are large grubs that are dried and salted. I’ve seen reality shows where contestants have to eat these in order to stay in the competition, but it was nowhere as bad as the shows made it out to be. 

Dr. Richard’s homestead, chicken coop, and homemade breakfast!
Local delicacies: mopani worms (left) and sour milk (right)!

Dean Stoios Joins The Wistar Institute as Chief Financial Officer

PHILADELPHIA (October 17, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious diseases, announces the appointment of Dean Stoios as Chief Financial Officer.

“We are thrilled to welcome Dean to Wistar,” said Dario C. Altieri, M.D., Wistar President & CEO, director of the Ellen and Ronald Caplan Cancer Center, and the Robert and Penny Fox Distinguished Professor. “He brings to the role a proven track record in financial leadership that will advance our strategic goals of driving breakthroughs in biomedical science and technology; develop more creative collaborations; will enable us to continue to grow our endowment and enhance our financial infrastructure and enterprise capabilities.”

Stoios comes to Wistar with more than 25 years of experience in strategic planning, financial management, and driving successful growth in both private and academic sectors. Most recently, Stoios served as CFO of the Coriell Institute for Medical Research, where he was instrumental in conceptualizing and executing a comprehensive vision of sustainable organizational growth, expanded NIH funding, and strategic planning that have been pivotal for the organization’s success. Prior to his role at Coriell, Stoios served in various leadership roles at clinical research organizations such as ICON PLC and Syneos Health and progressed through several roles at Aetna.

“I am very excited to become part of The Wistar Institute; its commitment to innovate through collaboration and its commitment to excellence in biomedical research have made it one of the most respected biomedical research organizations in the world,” said Stoios. “Wistar’s world-class scientists are committed to early-stage groundbreaking discoveries. I am honored to be a part of the leadership team.”

###

The Wistar Institute, the first independent, nonprofit biomedical research institute in the United States, marshals the talents of an international team of outstanding scientists through a culture of biomedical collaboration and innovation. Wistar scientists are focused on solving some of the world’s most challenging and important problems in the field of cancer, infectious disease, and immunology. Wistar has been producing groundbreaking advances in world health for more than a century, consistent with its legacy of leadership in biomedical research and a track record of life-saving contributions in immunology and cell biology. wistar.org

Notes from the Field: Dr. Ian Tietjen in Africa, Part 4

Dr. Ian Tietjen is a Research Assistant Professor in Wistar’s Montaner Lab, where he investigates traditional African medicinal compounds’ potential for drug origination against viruses like HIV. Dr. Tietjen travels to Africa to work with traditional healers to better understand the function of these compounds.

If you haven’t started this series with part one, click here.

7 August 2023 — Today was the opening session of our biomedical research project—a major undertaking to better identify and understand natural medicinal compounds. We’re meeting with the community before starting work to inform them about our collaboration with the healers and answer questions.

We began by meeting in the kgotla, which is the traditional meeting house of the village. Because Tutume is the local capital of the district, several Kgosi and Dikgosi, or chiefs and sub-chiefs, from Tutume and the neighboring villages all come to meet. These days everyone wears suits, but at minimum jackets, long skirts and covered shoulders are required in the kgotla. This is a formal session where the community can meet and give formal approval to our proposed plan. Anybody can attend, and in this case, it was broadcast on Botswana TV (BTV) and streamed on Facebook.

We each took a turn speaking about where we come from, what we hope to achieve, and what we hope to avoid. We also had a local poet present one of his works, and a local dancing troupe performed to traditional music. In return, the Secwepemc delegation sang and presented the Tutume Kgosi and a delegate of the Ministry of Education a copy of their book Secwepemc People, Land, and Laws (written by Ignace and Ignace), a 10,000-year history of their peoples. The Secwepemc and local healers are already starting to hit it off and trying to learn from each other how traditional medicines work.

Dr. Khumoekae Richard introducing the work we hope to do in Tutume.
Traditional Kalanga dancers on the left, and traditional Secwepemc singers on the right.
A super friendly cat back at the hotel.

8 August 2023 — Today was the big experimental day, and we all assembled into experimental groups to conduct collaborative research for the workshop. We brought a large amount of lab equipment and reagents as well as plant samples that were blinded to us (meaning we didn’t know what the samples were). In the morning, we ran an antioxidant assay, an assay to measure inhibition of alpha-glucosidase, and an assay to measure anti-trypsin activity. The antioxidant assay reagents spoiled, so we ran an alpha-glucosidase assay with both pure enzyme and pea sprouts, which have high levels of this enzyme.

Basically, alpha-glucosidase is an enzyme that catalyzes complex sugars and starches into simple sugars, which our body needs for energy. However, if there is too much sugar in the body, this can lead to diabetes. Alpha-glucosidase inhibitors from medicinal plants might be leads for future anti-diabetes therapies. We all worked together to run the assays on the blinded compounds.

Interestingly, we found that several medicinal plant extracts have alpha-glucosidase activity on their own, in the absence of pea shoots. Compared to the workshop group using the pure enzyme, we had the opposite results. So, one group found potential leads for anti-diabetes therapies, and we found leads for potentially treating low blood sugar.

The healers’ scientific judgment is sharp. We discussed how sample age and solvents could affect outcomes, and other healers commented on additional controls that could be added. One mentioned that just because this assay didn’t show activity for a certain plant doesn’t mean the plant is invalid — only that it didn’t work in this experiment. There was a lot of discussion among all us over lunch about other ways to target diabetes beyond alpha-glucosidase.

On the left, Richard, healers, and other community members test plant extracts for alpha-glucosidase activity. On the right, Kerstin and others test for anti-trypsin activity.
We have data!
All the workshop participants

After we conducted experiments, three participants gave result summaries and interpreted them. And their interpretations and results criticisms were spot-on. We then had a long discussion about the next steps of what we could do together. The healers were enthusiastic about future directions after the workshop, and they hope to continue collaborating with us to investigate other samples; there’s more work to be done, and everyone is excited to work together on it.

More scenes from Tutume:

Healer s talking shop

Wistar Institute HIV Researcher Wins Two Grants to Explore Using CAR T Cells as HIV Therapy

Dr. Daniel Claiborne of The Wistar Institute was recently awarded two grants to support studying an approach to optimize CAR T cells, a type of engineered cell, for use against HIV. Claiborne, a Caspar Wistar Fellow in Wistar’s Vaccine & Immunotherapy Center, received a Target Grant for $120,000 from amfAR, The Foundation for AIDS Research, and was also awarded a $65,000 grant from The Campbell Foundation.

The grants will enable Dr. Claiborne to engineer a panel of CAR T cells targeting non-traditional portions of the HIV viral envelope, or outer protein, and test them in a mouse model.

CAR T cells, or chimeric antigen receptor T cells, are patient-derived T cells that have been engineered to target and destroy a specific antigen on the surface of a cancer cell. They are considered “super charged” immune cells that act like a living drug, latching onto a tumor cell to terminate it. CAR T cells have been developed as an immunotherapy for cancer, but Dr. Claiborne explores their potential against HIV.

“My research has focused specifically on identifying the hurdles in repurposing CAR T cells for HIV, and how we can overcome those hurdles to develop an effective treatment,” explained Claiborne. “These grants will enable us to continue working toward that goal, test the approach, and uncover how we can use CAR T cells to develop a successful HIV therapy.”

Dr. Claiborne joined Wistar as a Caspar Wistar Fellow in 2021 from the Ragon Institute of MGH, MIT and Harvard, where he focused his work on better understanding T cells and CAR T cells for the treatment of HIV.

Launched in 2019, The Caspar Wistar Fellows Program is designed to offer exceptional autonomy and resources to recent Ph.D. or M.D. graduates with outstanding research records, who are prepared to take an accelerated path toward independence as principal investigators and join the next generation of scientific leaders.
Caspar Wistar Fellows are appointed for a three-year term with the possibility of extending or being considered for promotion. The Program enables scientists to quickly outfit their lab by offering start-up funds to purchase materials, hire laboratory staff, and access the state-of-the-art shared resources at the Institute.

About amfAR

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested more than $635 million in its programs and has awarded more than 3,500 grants to research teams worldwide.

About The Campbell Foundation

The Campbell Foundation was established in 1995 by the late Richard Campbell Zahn as a private, independent, nonprofit foundation dedicated to supporting clinical, laboratory-based research into the prevention and treatment of HIV/AIDS. It focuses its funding on supporting alternative, nontraditional avenues of research. The Campbell Foundation has given away more than $12 million since its inception.

Wistar Trainees Celebrate Postdoc Appreciation Week with Trivia Showdown

See if you can beat the winning team at the end of the article!

The air is electric with excitement and trepidation. Ph.D. students, research assistants, and postdoctoral fellows alike have gathered in The Wistar’s Grossman Auditorium for one of the year’s most anticipated scholarly summits: The Wistar Institute Postdoc Appreciation Week Trivia Extravaganza. 

Every year, the Wistar Trainee Association — currently led by Dr. Brennah Britten and doctoral candidate S.K. Reiser — celebrates Postdoc Appreciation Week, an opportunity to spotlight the contributions of postdocs to their labs. Because principal investigators (known more commonly as PIs) spend most of their time planning and managing the work of their laboratories, a good deal of on-the-ground science is led by postdoctoral fellows: Ph.D.-bearing scientists on the road to becoming PIs themselves. In the words of Wistar PI Daniel Claiborne, “By the time you’re a postdoc, you’re a scientific machine: from executing experiments to analyzing data to writing papers, you can (and do) do all the steps of producing research.”

But today, lab coats and nitrile gloves have been set aside in favor of raw determination. “We’re feeling all righty,” said one trivia team (team name: All Righty). “Oh, we’re very confident,” said another team, who’d named themselves, “The [Redacted Name of a Popular Burger Restaurant] Haters” — so-called because they had successfully lobbied for a trivia luncheon of Mexican food in lieu of hamburgers. 

Contestants weathered four rounds: general science trivia; Wistar-specific trivia; a picture round requiring the recognition of esoteric scientific instruments; and Philadelphia trivia provided by one trivia-enthused Wistar PI. 

S.K. Reiser and doctoral candidate Ilan Kirkel alternated as hosts, each holding court with merciless adherence to the competition’s rigor. “You either get full marks — or nothing!” said Ilan when asking which two elements were liquid at room temperature. 

The competition kept a brisk pace, only pausing when Dr. Jason Diaz , education director in the Hubert J.P. Schoemaker Education and Training Center, interrupted to lament  everyone’s missing an easy question in the Wistar trivia round. “If you’ve ever passed our office, you should have known whose ashes are kept here — I’m very disappointed!” 

After a whirlwind three-way race between the top teams — [Redacted Burger Restaurant] Haters, Shine, and D&D — the final winner-take-all event was revealed: a Wistar yo-yo competition, with authentic Wistar-branded yo-yos. Dr. David Stieg of the [Burger] Haters faced off in the dramatic finale against Dr. Brennah Britten of Shine. But after Dr. Stieg walked the dog, catted the cradle and generally wowed the room with his yo-yo prowess, the winner became clear.

The winners went home with Wistar goodies, a sense of accomplishment, and 23 points to their name — plus the satisfaction of having enjoyed their preferred lunch.

Can you beat the winning Wistar trainees? Test your knowledge below!

For each correct answer, award yourself one point. The photo round is not included:; to test your score against the winning team, add 5 points to your total, which is what the winning team scored in the photo round.

QUESTIONS

Round One: General Science

  • What is the average lifecycle of a red blood cell?
  • Which two elements on the periodic table are liquids at room temperature?
  • At what temperature are Celsius and Fahrenheit equal?
  • What does LASER stand for?
  • How many bones do sharks have in their bodies?
  • What is the only planet that spins clockwise?
  • What instrument is used to measure wind speed?
  • What is the smallest named interval of time?

Round Two: Wistar History

  • Who founded The Wistar Institute?
  • When was The Wistar Institute founded?
  • Who was the first female scientist at Wistar?
  • How many PIs are there at Wistar?
  • What was the first vaccine developed at Wistar?
  • Whom is the tower at Wistar named after?
  • Which cytokine was discovered at Wistar?
  • Whose ashes are kept at the Wistar Institute?

Final Round: Philadelphia Trivia, Courtesy of a Generous Wistar PI

  • When it opened in 1874, which family attraction —the first of its kind in America—charged visitors 25 cents to enter?
  • Philadelphia’s border with New Jersey is created entirely by what river?
  • A historic street in Philadelphia, with 32 houses built between 1703 and 1836, is called what?
  • What museum at the College of Physicians of Philadelphia contains historical anatomical specimens, wax models, and antique medical equipment?
  • What dialect, primarily spoken by Mennonites and Amish, is spoken by over 300,000 people and is named as a combination of where it was developed and the language it is a dialect of?
  • Identify the following pattern: 40 37 36 33 30 22 19
  • In 1775 Philadelphia, John Behrent built the first American version of what instrument?
  • A statue of whom sits at the top of Philadelphia city hall?

Bonus: Identify the following Wistar PI:

  • “This PI has grandparents born in Ecuador, Ireland and Spain.  They are the first in their family to graduate college, and their favorite movie is The Warriors.”

ANSWERS

Round One: General Science

  • What is the average lifecycle of a red blood cell? 120 days
  • Which two elements on the periodic table are liquids at room temperature? Mercury and bromine
  • At what temperature are Celsius and Fahrenheit equal? Negative 40
  • What does LASER stand for? Light Amplification by Stimulated Emission of Radiation
  • How many bones do sharks have in their bodies? Zero (sharks only have cartilage)
  • What is the only planet that spins clockwise? Venus
  • What instrument is used to measure wind speed? Anemometer
  • What is the smallest named interval of time? The Planck Time/Duration/Interval

Round Two: Wistar History

  • Who founded The Wistar Institute? General Isaac Jones Wistar
  • When was The Wistar Institute founded? 1892
  • Who was the first female scientist at Wistar? Helen Dean King
  • How many PIs are there at Wistar? 34 (33 also acceptable)
  • What was the first vaccine developed at Wistar? Rubella (rabies also acceptable)
  • Who is the tower named after? Robert and Penny Fox
  • Which cytokine was discovered at Wistar? Interleukin-12 (IL-12)
  • Whose ashes are kept at the Wistar Institute? Isaac Wistar’s

Final Round: Philadelphia Trivia, Courtesy of a Generous Wistar PI

  • When it opened in 1874, which family attraction —the first of its kind in America—charged visitors 25 cents to enter? The Philadelphia Zoo
  • Philadelphia’s border with New Jersey is created entirely by what river? The Delaware River
  • A historic street in Philadelphia, with 32 houses built between 1703 and 1836, is called what? Elfreth’s Alley
  • What museum at the College of Physicians of Philadelphia contains historical anatomical specimens, wax models, and antique medical equipment? The Mütter Museum
  • What dialect, primarily spoken by Mennonites and Amish, is spoken by over 300,000 people and is named as a combination of where it was developed and the language it is a dialect of? Pennsylvania Dutch/German
  • Identify the following pattern: 40 37 36 33 30 22 19 SEPTA Trolley Lines
  • In 1775 Philadelphia, John Behrent built the first American version of what instrument? Piano
  • A statue of whom sits at the top of Philadelphia city hall? William Penn

Bonus: Identify the following Wistar PI:

  • “This PI has grandparents born in Ecuador, Ireland and Spain.  They are the first in their family to graduate college, and their favorite movie is The Warriors.” Dr. Maureen Murphy

Wistar Salutes Celebrates Hispanic Heritage Month

“If you want to make sure that you’re creative and innovative, you need to have a big table and people at it with a lot of different perspectives,” said Marie A. Bernard, M.D., NIH Chief Officer for Scientific Diversity, during Wistar’s Diversity in Science Series. “Traditionally, science academia has been very pyramidal, you get to the peak where there’s only a small number of people, but you need those other perspectives. If you don’t have those diverse minds at the table, you’re missing out on talent. If we are going to maintain our leadership role in biomedical research across the globe, we need to take advantage of all that talent.”

In honor of Hispanic Heritage Month, we are sharing the narratives, perspectives, and points of view of five dynamic scientists living in Philadelphia with cultural roots in South America and Spain. Angela Rios Angula (in the Chen lab), Segundo Del Aguila (in the Villanueva lab) and Rocio Inga (in the Villanueva lab) are from Peru. Marta Tarquis Medina (in the Escolano lab) is from Spain. And Maria Belen Palacio (in the Escolano lab) is from Argentina.

Together, they discussed the initial spark that put them on a path to science; the journey of building community and dynamic careers; and connecting with others through celebrating the vast and varied experiences of Hispanic people from different backgrounds.

Snapshots of the Beginning Scientist

Segundo Del Aguila: My high school biology teacher was a scientist. What I mean is she thought and asked questions like a scientist—she was pragmatic. I liked the way she thought about and viewed everyday problems, but especially how she arrived at the ideal question that got to the heart of a problem. She was a biologist, and because of my interest in understanding life, I decided to take that route too.

In Peru’s capital city of Lima, I knew of three big universities that had biology programs, and I managed to get a scholarship to the best one in research—Cayetano Heredia Peruvian University. I remember that, during the application process, you could write down five different career tracks, but I put only one: biology. The academic advisor told me I had blank spaces and should fill out more, but I knew it was only biology for me.

Angela Rios Angula: When I was young, I was very shy but also very curious. Plants made me wonder how, why and where do they grow? That led me to understand how bacteria survive, and that led me to the human body. Because of this curiosity and passion, I decided to become a scientist; I knew I was not going to give up on whatever I started.

Rocio Inga: I’m from the same university as Angela and Segundo. Our university has only biomedical careers, so it’s very specialized. It is connected to a big hospital and other biomedical research institutes, so we could start learning in the lab early on, within a nurturing scientific environment.
I too was curious as a kid—always looking at bugs and plants and wondering about how they work. My father is a chemical engineer, and he told me about biochemistry as a career, and I’m glad I followed his advice. While taking courses at the university, it was the molecular biology course that really made me passionate. I’ve been fortunate to have many different science career experiences; I’ve worked many years on the molecular biology of Leishmania parasites, worked with cancer cells, worked at different research institutes, and taught at university.

Marta Tarquis Medina: I was super interested in medicine and health care when I was young but knew being a doctor was stressful and demanding. My school had a mini laboratory and good mentors, and I realized I liked being in a laboratory and could have a career in science. I got my bachelor’s degree in biology, left Spain to get my master’s in Germany, and left Germany with a Ph.D. in diabetes.

Belen Palacio: My journey doesn’t go back that far. My high school principal invited a German friend to give a talk about his chemical engineering career working in nanomaterials. I asked what I needed to study to obtain a similar career. But in college, I didn’t like chemistry much, but I did like biology. I tracked into biotechnology and pursued a Ph.D. in developmental biology.

When I was looking for a postdoctoral fellow position, I knew one thing for sure: I wanted my work to mean something to society. I don’t research for the pleasure of research. There must be a greater purpose.

Finding Community

Rocio: We don’t celebrate specific themes, but we celebrate together. We watched the World Cup, we celebrated Peruvian Independence on July 28. We connect over lunch and coffee. We bring back sweets and desserts from our trips home to share with everyone in the lab.

Belen: I’m very family-oriented, so it’s been hard for me. I came abroad and left my whole family in Argentina. The first few months were shocking because I missed my family, my friends and my routine. So, being new to the U.S. and Philadelphia, you must find a new routine. You go out and try to find your people, but you need to build a new community.

Marta: A new scientist comes to Wistar and we ask them, “Do you speak Spanish? Come meet us.” Then Rocio gathers us all together! Rocio, you bring everyone together.

Rocio: Yes, I always liked to gather people together especially those who have recently arrived at Wistar. It’s a chance for them to meet and make new friends. And if they need help with anything, we can help.

Biomedical Role Models

Belen: I didn’t have a role model during my Ph.D. When I came to Wistar and met Amelia, I was stunned how a person can influence your science so much and how they can help you become a better scientist. In Germany during my postdoctoral training, my PI wasn’t around much, and it seemed like I was just carrying out tasks. I had completely lost my passion and almost gave up on science. Then I came to Wistar, and Amelia showed me a new and completely different science panorama. She is encouraging at every step and pushes you in a positive way to become your best version.

Segundo: Jessie is a great mentor. She is my role model, and I am on a similar path to science as she was. We came to the U.S. after studying at the same university. She started as a research assistant and then applied for a Ph.D. program, which is exactly what I’m planning to do. Even though I don’t have a Ph.D., I’m trying to learn and mature as a student would in a Ph.D. program. I will try to be an inspiration for others starting out in scientific careers.

Diversity Matters

Belen: For the next generation of Hispanic scientists, they need to build the foundations of their scientific path. I ended up in immunology, but I didn’t study immunology. When I was getting my Ph.D., I had to learn why I was doing each experiment because if something went wrong, you had to fix it. I knew exactly what each product was and each step in an experiment. I made things from scratch. In my lab, it was not an option to buy a kit or fancy equipment. Here in the U.S., you can buy a kit and in four days you have the result, but do you understand what each step means to your sample or to what you’re doing?

Marta: Regarding science funding in Spain, it’s my view that we must learn to solve problems in a different way. We must think outside the box because we may not have the money to buy the equipment or supplies for an experiment. So we must get to the same conclusion, through a different approach. I think people that come from poorer countries have an out-of-the-box thinking that enriches the lab.

Belen: Try doing science in a developing country. There are many things scientists in the U.S. take for granted because of the technology here. For example, it would take me a year to get an antibody from the U.S. to arrive to Argentina because of customs. This forces us to fully understand the methods of an experiment. In my lab in Argentina, if something doesn’t work, you can’t get a new one or try it again. When you don’t have extra funds, you really think deeply about the protocols and how you will conduct an experiment. You only have one try. Make sure you can accomplish what is important.

Rocio: It’s good to have scientists from different backgrounds, with different ways of seeing things, using different approaches in science. I think that’s the beauty of science: to come together from differences and approach the same problem. And even the youngest people in the lab may think they can’t contribute yet, but even their questions and ideas help to solve a scientific problem.

Wistar President and CEO Dario Altieri, M.D., honored by Justinian Society of Philadelphia for Civic Engagement and Leadership

Dario C. Altieri, M.D., president and chief executive officer of The Wistar Institute will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities of scholarship, civic leadership and integrity.

The Justinian Society, an organization of attorneys, judges and law students of Italian-ancestry who promote continuing education in law and uphold a positive image of Italian-Americans, will recognize the Wistar leader at their annual scholarship reception and luncheon Tuesday, Oct. 10 at the Union League in Philadelphia.

Wistar is the nation’s first independent life science research organization and a global leader in collaborative biomedical breakthroughs leading to the development of novel therapies and vaccines. Through its Hubert J.P. Shoemaker Education and Training Center, top Wistar faculty collaborate with industry experts to advance a well-trained, sustainable life science workforce with programs ranging from pre-apprenticeships through postdoctoral fellowships.

“Just as the Justinian Society has a long-standing history supporting the education of the next generation of legal scholars in our community, at Wistar, we recognize that it is in preparing a diverse and inclusive talent pipeline that today’s discoveries will lead to tomorrow’s cures,” said Dr. Altieri. “I am deeply honored to be recognized by this esteemed Italian-American society committed to advancing professional, academic, civic and cultural excellence here in Philadelphia for the greater good of our global community.”

As president of The Wistar Institute since 2015, Dr. Altieri’s extensive experience working alongside academic, federal, local government, pharma and key life science stakeholders has helped shape the culture of biotechnology in Philadelphia. Wistar now ranks among the nation’s top three drivers of innovation, research and tech transfer, and in the top percentiles for both innovation and research among leading academic and research-related institutions.

Born and educated in Milan, Italy, Dr. Altieri joins past Justinian Italian-American honorees Paul Tufano, general counsel of the Commonwealth of Pennsylvania’s Governor Tom Ridge 1995–1999; Samuel A. Alito, associate justice of the Supreme Court of the United States, and Antonin Scalia (deceased), former associate justice of the Supreme Court of the United States.

A physician, cancer researcher and executive leader, Dr. Altieri initially joined Wistar in 2010 as the first chief scientific officer and director of its National Cancer Institute (NCI)-designated Cancer Center following faculty appointments at Scripps Clinic and Research Foundation in La Jolla, California; Yale University and the University of Massachusetts. He was appointed chief executive in 2015, and continues to direct what is now the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. He also serves as the Robert and Penny Fox Distinguished Professor in Wistar’s Immunology, Microenvironment and Metastasis Program.

“Cooperation, education and inclusion—three fundamental tenets of the Justinian Society—are as imperative in the life sciences sector as they are in the legal profession,” said Barbara A. Capozzi, president of the Justinian Foundation. “As we celebrate the next generation of legal and judiciary leaders through academic scholarships promoting the principles of good fellowship, maintaining honor and dignity of the legal profession, performing civic duties, administering justice and promoting the study of law, is our distinct privilege to recognize Dr. Altieri as an Italian-American leader to be emulated in our region – and beyond.”

Event details:
For tickets to the Oct. 10 Justinian Society of Philadelphia annual scholarship reception and luncheon at the Union League, contact Joanne Crane Tsucalas at jct.uta@att.net.

###

The Wistar Institute, the first independent, nonprofit biomedical research institute in the United States, marshals the talents of an international team of outstanding scientists through a culture of biomedical collaboration and innovation. Wistar scientists are focused on solving some of the world’s most challenging and important problems in the field of cancer, infectious disease, and immunology. Wistar has been producing groundbreaking advances in world health for more than a century, consistent with its legacy of leadership in biomedical research and a track record of life-saving contributions in immunology and cell biology. wistar.org.

The Justinian Foundation is a 501(c)3 nonprofit organization founded in 1996. The charitable arm of The Justinian Society (1935), the Foundation’s sole purpose is to provide financial assistance to law students currently enrolled in an accredited law school in a program of study leading to a juris doctor degree. Scholarship candidates must be admitted to an accredited law school within a one hundred (100) mile radius of the City of Philadelphia and must be entering, at a minimum, their second year; or must meet the requirements for specific scholarships. All gifts are tax deductible. In addition to our general scholarships, our two named scholarships include the Jules Fiorvanti Scholarship which is granted to a student at LaSalle University interested in the study of law. The Richard F. Furia, Esquire Scholarship is granted to the winner of an essay contest with a focus on advocating against stereotyping and defamation. www.justinian.org/foundation.php

The Justinian Society is a legal organization comprised of attorneys, judges and law students of Italian-ancestry. Founded in 1925, the Society is located in Philadelphia. The Justinian Society members are engaged in activities directed toward fostering a spirit of good fellowship, maintaining honor and dignity of the legal profession, performing civic duties, administering justice, and promoting the study of law. The Justinian Society promotes continuing education in law, supports the advancement of qualified and distinguished Justinians in public office, serves the Italian-American legal profession and the community, and strives to uphold a positive image and take action against negative stereotyping against Italian-Americans.

Wistar 101

Special Event
Wednesday, Oct. 11, 2023

12:00 p.m. to 1:00 p.m.

Wistar 101 virtual event offers a first-hand update from our President and CEO Dr. Dario Altieri on all things Wistar – the latest scientific breakthroughs and goals for the future – followed by a Q&A .

For information, please contact Lynn Keily, Development Operations Associate, at LKeily@Wistar.org or 215.898.3943.

Continue reading

EVs Drive Cancer. A Wistar Scientist Wants to Know How

Dr. Irene Bertolini of the Altieri Lab investigates extracellular vesicles and their role in metastasis

When cancer spreads, cancer kills. Cancer’s ability to spread to other parts of the body — a process known as metastasis — makes the disease dangerous and more complicated both for the patient and the medical professionals treating the disease. Decades’ worth of cancer research has investigated the multitude of factors that can drive metastasis.

One of these factors is the presence of extracellular vesicles, or EVs, the research interest of Irene Bertolini., Ph.D., an associate staff scientist in Wistar’s Altieri Lab. Her research shows that EVs from cancer cells can contribute to the conditions that allow cancer to flourish and spread in breast cancer, the second most common cancer in women.

Vesicles are small particles created by cells that contain biological materials. When a vesicle leaves a cell, that vesicle is said to be extra-cellular. Cancerous cells emit EVs just like regular cells, but, being cancerous in origin, breast cancer EVs can carry carcinogenic properties.

Dr. Bertolini investigates the connection between breast cancer EVs and the tumor microenvironment, which can be thought of as the biological garden that cancer grows in. Like garden plants, cancers grow and spread better in certain conditions. Cancer cells work to foster those conditions, and Dr. Bertolini found that EVs produced by hypoxic (oxygen-deficient) breast cancer cells promote a variety of carcinogenic and metastatic conditions.

Using EVs from hypoxic breast cancer cells, Dr. Bertolini found that EVs increase angiogenesis, the process that forms new blood vessels. When new blood vessels form around cancer, the cancer cells use them to siphon more of the body’s nutrients, which allows cancer to grow and potentially metastasize.

Dr. Bertolini’s research also revealed that the EVs showed increased packaging of a protein called HIF1α, which has been linked to a variety of metastatic cancers. And relative to controls, tumor formation & growth in mice treated with cancer-derived EVs was significantly more rapid.

“EVs from cancerous cells basically transmit packets of potent cancer-causing material,” said Bertolini. “Where EVs move, conditions conducive to cancer follow.” Because EVs can move beyond cancerous cells and into healthy tissue, she says, they have the capacity to drive metastasis.

To that end, Dr. Bertolini plans to study the role of hypoxic breast cancer EVs in metastasizing to the liver, specifically. So far, she has found that EVs do indeed migrate to the liver, where she’s observed pro-cancer effects like increased angiogenesis and reduced counts in anti-tumor T-cells.

“Understanding why EVs help cancer spread is the first step in understanding how to stop them,” said Dr. Bertolini. “If we know what they do and how they do it, that’s half the battle.”